PHARMAC's bi-monthly newsletter about the management of hospital medical devices.
Issue 42 - February 2021
As of 1 April 2021, the Pharmaceutical Schedule will include over 130,000 contracted line items from over 100 suppliers. These contracts cover approximately $378 million of annual DHB hospital expenditure on medical devices.
All contracted products are listed in the Addendum for Medical Devices in Section H, Part III of the Pharmaceutical Schedule.
New agreements with suppliers
The following agreements have been completed since 12 February 2021 (the previous issue of Device Advice).
We notify all new supplier agreements on our website in the section called Consultations and Decisions.
The following proposals have opened for consultation since 12 February 2021 (the previous issue of Device Advice).
We list all new proposals on our website in the section called Consultations and Decisions.
Keep track with what’s happening in each category on our website.
Since September 2020, PHARMAC has released Registrations of Interest (“ROI”) for several categories where NZ Health Partnerships have run competitive processes. Contracting as a result of these processes is in progress and agreements will be notified over the coming months.
Contracting is in progress for the Laboratory Equipment and Consumables category resulting from the 2018 Request for Proposals (RFP). Agreements in this category will be consulted on throughout 2021.
Future Procurement Opportunities have been released for additional categories where PHARMAC intends to release similar ROIs in 2021.
Since the early stages of COVID-19, PHARMAC has been actively working with our contracted suppliers and wider industry groups to identify supply risks and impacts to the general supply chain. PHARMAC has provided direct support to several of our contracted suppliers; this support has included leveraging our networks to ease logistics issues through to temporary financial support for increased freight costs in material cases.
We expect to continue seeing some challenges in the general supply chain and with international manufacturing disruptions and will continue to manage this as appropriate. If you are experiencing any issues with the supply of PHARMAC contracted medical devices, please contact us at firstname.lastname@example.org.
Progressing our work
The first meeting of the DHB Strategic Medical Devices Advisory Group was held in Wellington on Friday, 26 March. This Group was established to provide guidance on our work to develop the management approach for the next phase of our role in hospital medical devices (Fairer Access), and how we can best contact and engage with key groups within DHBs. Some great insights came from the first session, and we look forward to future sessions providing the same.
As part of our ongoing work, we will engage with stakeholders to further develop and test the operational details needed to move to Fairer Access, including representatives from DHBs, professional organisations like colleges and societies, suppliers. We will also be engaging with groups representing Maori, Pacific, consumer, and disability views to determine how best to incorporate these into our work. These are among the groups we’ll be seeking more detailed input from as we develop the operational approach as part of our ongoing work in medical devices. Following this, we will broaden our engagement to include a wider range of stakeholders.
PHARMAC is currently working with DHB Chief Financial Officers, Chief Operating Officers, and the Procurement Operations Advisory Group (POAG) members to identify candidates for a group discussion on clinical equipment.
In addition to providing knowledge of clinical equipment procurement processes, the attendees will help us identify any additional relationships, dependencies, or risks that might impact our approaches.
We will also be presenting on our devices work at the MTANZ HealthTech conference in June. We intend to use this session to share our thinking about the decision-making approach, how this would be tailored to the type of funding change we are considering, and what we would take into account.
Future Procurement Opportunities replacing Annual Procurement Plan
In line with changes to reporting requirements from the New Zealand Government procurement In line with changes to reporting requirements from the New Zealand Government procurement branch of the Ministry of Business, Innovation and Employment PHARMAC will no longer produce an Annual Procurement Plan (APP). Instead, we intend to publish Future Procurement Opportunities (FPOs) for potential contract opportunities that the Government Procurement Rules apply to.
In line with changes to the Government Rules of Procurement, we will publish FPOs as they are identified on the Government Electronic Tenders Service (GETS). The GETS website provides a complete list under the FPOs section and if an FPO matches your ‘tender subscription preferences’, you will receive a notification in the daily mail run.
Feedback on our work, our website, or this newsletter is welcome:
Subscribe to Device Advice to keep up to date with developments relating to the management of hospital medical devices.